They're still sticking to their timelines about when Renal (in particular) comes on market. Also: the market for renal has always been ~US$500m/yr. But it looks like their long term aspiration is more like $US1b so that's a good long term sign.
CB presenting at Jefferies London this Thursday (3am), page-6
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.445(2.28%) |
Mkt cap ! $6.645B | |||
| Open | High | Low | Value | Volume |
| $19.85 | $20.00 | $19.70 | $11.13M | 561.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 845 | $19.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.97 | 57 | 8 |
View Market Depth
| Last trade - 12.13pm 20/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |